{"id":43936,"date":"2022-05-16T14:01:22","date_gmt":"2022-05-16T12:01:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/"},"modified":"2022-05-16T14:01:22","modified_gmt":"2022-05-16T12:01:22","slug":"iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/","title":{"rendered":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference"},"content":{"rendered":"
\n

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc.<\/a> (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022.\n<\/p>\n

<\/a><\/p>\n

\nThe on-demand presentation will be available for viewing beginning Tuesday, May 24 at 7:00 a.m. ET and can be accessed on the Investor \/ Events & Presentations section of the Iveric Bio website at www.ivericbio.com<\/a>. An archived replay of the presentation will be available on the Company\u2019s website immediately following the conference and for at least 30 days thereafter.\n<\/p>\n

\nAbout Iveric Bio<\/b>\n<\/p>\n

\nIveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The Company is committed to having a positive impact on patients\u2019 lives by delivering high-quality, safe and effective treatments designed to address debilitating retinal diseases including earlier stages of age-related macular degeneration. For more information on the Company, please visit www.ivericbio.com<\/a>.\n<\/p>\n

\nForward-looking Statements<\/i><\/b>\n<\/p>\n

\nAny statements in this press release or made during the presentation referenced herein about Iveric Bio\u2019s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including those described in the \u201cRisk Factors\u201d section of public filings made by Iveric Bio with the U.S. Securities and Exchange Commission. Any forward-looking statements represent Iveric Bio\u2019s views only as of the date of this press release or the presentation, as applicable. Iveric Bio anticipates that subsequent events and developments may cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so unless required by law.<\/i>\n<\/p>\n

\nISEE-G<\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Kathy Galante
\n
Senior Vice President, Investor Relations
\n
kathy.galante@ivericbio.com<\/a>\n<\/p>\n

\nor\n<\/p>\n

\nMedia Contact:<\/b>
Jeannie Neufeld
\n
Senior Director, Public Relations and Communications
\n
jeannie.neufeld@ivericbio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022. The on-demand presentation will be available for viewing beginning Tuesday, May 24 at 7:00 a.m. ET and can be accessed on the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-43936","6":"format-standard","7":"category-industry"},"yoast_head":"\nIveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022. The on-demand presentation will be available for viewing beginning Tuesday, May 24 at 7:00 a.m. ET and can be accessed on the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T12:01:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference\",\"datePublished\":\"2022-05-16T12:01:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/\"},\"wordCount\":358,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220512005703\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/\",\"name\":\"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220512005703\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"datePublished\":\"2022-05-16T12:01:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220512005703\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220512005703\\\/en\\\/1151895\\\/21\\\/Iveric_Bio_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/","og_locale":"en_US","og_type":"article","og_title":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend","og_description":"PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Pravin U. Dugel, M.D., President, will present a corporate overview at the H.C. Wainwright Global Investment Conference, being held from May 23-26, 2022. The on-demand presentation will be available for viewing beginning Tuesday, May 24 at 7:00 a.m. ET and can be accessed on the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-16T12:01:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference","datePublished":"2022-05-16T12:01:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/"},"wordCount":358,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/","url":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/","name":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","datePublished":"2022-05-16T12:01:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220512005703\/en\/1151895\/21\/Iveric_Bio_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iveric-bio-to-participate-in-the-h-c-wainwright-global-investment-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Iveric Bio to Participate in the H.C. Wainwright Global Investment Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=43936"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43936\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=43936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=43936"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=43936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}